Skip to content
YCS21· Other

Promakhos Therapeutics

A therapeutics platform for curing inflammatory disorders

ActiveChecked 17h ago
Batch
S21
Status, per YC
Active
Team size
2
HQ
Boston, MA
In S21391 companies, 34% AI
promakhos.comYC profile

Founders

Not read from YC yet; the weekly run fills these in.

Same space

About Promakhos Therapeutics

We are building a platform of bacterial molecules to awaken our body’s innate ability to control inflammation and heal. Our first indication is Crohn’s Disease, which affects over 500,000 Americans at an annual cost of $10B. After Crohn's disease, we are going for type 1 Diabetes and Multiple Sclerosis.

Boston, MA, USA

Promakhos Therapeutics: questions

Which YC batch was Promakhos Therapeutics in?

Promakhos Therapeutics was in Y Combinator's Summer 2021 batch (S21).

Is Promakhos Therapeutics still active?

Y Combinator lists Promakhos Therapeutics as active.

Where is Promakhos Therapeutics based?

Promakhos Therapeutics lists Boston, MA, USA as its location on YC's directory.

Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.

Weekly: new YC data, AI and devtools companies and status changes, Mondays.